Fujifilm Diosynth Biotechnologies Texas LLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Fujifilm Diosynth Biotechnologies Texas LLC
US Forming Industry Consortia To Prepare For Future Pandemics And Global Supply Chain Disruptions
HHS agencies look to build on COVID-19 experience by developing quicker public/private responses to pandemics and supply chain threats.
BARDA Lays Out Vision For Next Pandemic: Vaccines For The US Within 130 Days
Federal agency seeks dialogue with industry on how to enable surge capacity for pandemic vaccines without cutting back on other production.One key factor: workforce development.
As Emergent Partnership Dissolves, BARDA Looks To Revamp Post-COVID Pandemic Preparedness
BARDA terminates CIADM contract in wake of vaccine cross-contamination incident, begins discussion with industry about next steps for rapid pandemic response capabilities.
- Contract Research, Toxicology Testing-CRO
- Gene Therapy, Cell Therapy
- Synthesis Technologies, Production Processes
- Other Names / Subsidiaries
- Kalon Biotherapeutics LLC
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.